Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05832008 · ClinicalTrials.gov registry record · NA
Increasing Adherence to Lung Cancer Screening
A NA study of Lung Cancer and Adherence, Patient, sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- NA
- Development phase
- 825
- Enrollment target
- 1
- Study location
NCT05832008: Active NA study of Lung Cancer and Adherence, Patient, sponsored by Abramson Cancer Center at Penn Medicine.
NCT05832008 is a NA study of Lung Cancer and Adherence, Patient that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 825 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05832008, a NA study of Lung Cancer and Adherence, Patient, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 825 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clinicians will be invited to one-time semi-structured interview \& survey to identify individual \& system-level factors that may restrict or enhance the impact of strategies.
Primary Outcome
Number of completed low-dose computed tomography (LDCT) scans among adults who are due for annual screening based on evidence-based guidelines.
Conditions Studied
Interventions
- BEHAVIORAL Patient Nudge
- BEHAVIORAL Clinician Nudge
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT05832008 still lists
NCT05832008 is an interventional study that assigns participants to a tested intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (12% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Nudge is the first listed.
NCT05832008 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05832008 about?
NCT05832008 is a clinical study titled "Increasing Adherence to Lung Cancer Screening". Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clini...
What is the current status of trial NCT05832008?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 825 participants. The study started on 2023-10-18. Estimated completion is 2026-06-01.
What conditions does trial NCT05832008 study?
This clinical trial studies the following conditions: Lung Cancer, Adherence, Patient.
What interventions are being tested in trial NCT05832008?
The interventions under investigation include: Patient Nudge (BEHAVIORAL), Clinician Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT05832008?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05832008 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05832008's enrollment target sits among peer trials
825 54th of 409 higher than 356 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT07318077 · 825 participants · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI